A Study to Investigate the Safety, Tolerability, PK and PD of MG1113 in Healthy Subjects and Hemophilia Patients

NCT03855696 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

BIOLOGICAL: MG1113
OTHER: Placebo of MG1113

Sponsor

Green Cross Corporation

Collaborators

[object Object]